|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
1996-4-17
|
|
pubmed:abstractText |
Cardiac hypertrophy is a physiologic response that allows the heart to adapt to an excess hemodynamic load. We hypothesized that inducing cardiac hypertrophy with recombinant human growth hormone might be an effective approach to the treatment of idiopathic dilated cardiomyopathy, a condition in which compensatory cardiac hypertrophy is believed to be deficient.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
28
|
|
pubmed:volume |
334
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
809-14
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8596546-Adult,
pubmed-meshheading:8596546-Cardiomyopathy, Dilated,
pubmed-meshheading:8596546-Echocardiography, Doppler,
pubmed-meshheading:8596546-Female,
pubmed-meshheading:8596546-Growth Hormone,
pubmed-meshheading:8596546-Heart Ventricles,
pubmed-meshheading:8596546-Hemodynamics,
pubmed-meshheading:8596546-Humans,
pubmed-meshheading:8596546-Male,
pubmed-meshheading:8596546-Middle Aged,
pubmed-meshheading:8596546-Myocardium,
pubmed-meshheading:8596546-Recombinant Proteins
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
A preliminary study of growth hormone in the treatment of dilated cardiomyopathy.
|
|
pubmed:affiliation |
Department of Internal Medicine, University Federico II, Naples, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
